PhillyDeals: Acquiring an opportunity to test drug-industry investments
Posted on Sunday, Dec 09, 2012
Janney Capital Markets is betting on a drug-industry revival.
The Philadelphia investment bank last week hired a team of dealmakers and stock analysts from bankrupt San Francisco stock-trading and research firm ThinkEquity L.L.C. to hunt for deals and profit among emerging pharmaceutical firms, medical device-makers, and biotech developers.